VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 206 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,919,676 | +442658.1% | 631,769 | +999.7% | 0.00% | +200.0% |
| Q1 2023 | $1,337 | +15.7% | 57,451 | +25.7% | 0.00% | 0.0% |
| Q4 2022 | $1,156 | -100.0% | 45,691 | -84.2% | 0.00% | -66.7% |
| Q3 2022 | $5,575,000 | -68.1% | 289,170 | -57.9% | 0.00% | -72.7% |
| Q2 2022 | $17,503,000 | -85.7% | 687,199 | -85.5% | 0.01% | -83.1% |
| Q1 2022 | $122,124,000 | +201.4% | 4,748,194 | +390.6% | 0.06% | +209.5% |
| Q4 2021 | $40,523,000 | +463.8% | 967,825 | +485.9% | 0.02% | +425.0% |
| Q3 2021 | $7,188,000 | -52.1% | 165,173 | -47.9% | 0.00% | -55.6% |
| Q2 2021 | $14,995,000 | +624.4% | 317,150 | +685.4% | 0.01% | +800.0% |
| Q1 2021 | $2,070,000 | -62.4% | 40,379 | -80.4% | 0.00% | -75.0% |
| Q4 2020 | $5,508,000 | +226.1% | 205,679 | +399.0% | 0.00% | +33.3% |
| Q2 2020 | $1,689,000 | – | 41,222 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |